Search Results

Ora, Inc., the foremost global ophthalmology contract research organization, announced a strategic, exclusive partnership with the Singapore Eye Research Institute, a world-renowned institution for cutting-edge eye research and ophthalmic preclinical studies.

EnGeneIC, a clinical-stage biopharmaceutical company pioneering the development of a First-in-Class targeted nanocell for cancer therapy has announced strategic partnerships with Singapore Institute of Advanced Medicine Holdings and Singapore Medical Incorporation.

ANEW MEDICAL, INC. announces a strategic partnership with Drs. Makoto Suzuki, Craig and Bradley Willcox, Richard Allsopp, and Michio Shimabukuro of Japan’s Okinawa Research Center for Longevity Science for the research and development of ANEW’s patented Klotho gene therapy in enhancing longevity and reducing age-related diseases.

SCG Cell Therapy and the Agency for Science, Technology and Research announced the launch joint laboratories for cellular immunotherapies.

In response to the pressing need of effective treatments for these metabolic disorders, researchers at the led by Prof. Jin Hee Ahn from Gwangju Institute of Science and Technology (GIST) meticulously developed compound 11c, a novel peripheral 5HT2A antagonist.

CytoMed Therapeutics Limited announced that it has entered into a Research Collaboration Agreement with Sengkang General Hospital Pte Ltd, a public hospital in Singapore and a member of the SingHealth group to establish proof-of-concept use of an injectable cartilage regeneration therapy that has been developed with donor-sourced, umbilical cord-derived mesenchymal stem cells to treat cartilage injury.